Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Mar 22;23(7):3437.
doi: 10.3390/ijms23073437.

A Strategic and Worldwide Cooperative Challenge Required for the Next Generation of Platelet Concentrates

Tomoyuki Kawase  1
Affiliations
Editorial

A Strategic and Worldwide Cooperative Challenge Required for the Next Generation of Platelet Concentrates

Tomoyuki Kawase. Int J Mol Sci. .

Abstract

Blood-derived biomaterials, which are represented by platelet-rich plasma (PRP) or more recently by platelet-rich fibrin (PRF), have been used in regenerative therapy for almost 30 years [...].

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
A scheme of mechanisms of PRP action. (a) A general concept for the scenario of PRP-induced tissue regeneration. (b) A proposed adjuvant effects of PRP especially in the case of lower spontaneous regenerative potential.
Figure 2
Figure 2
A theoretical scheme for the balance between host’s spontaneous regenerative potential and PRP potency and the effects of its balance on the success of PRP therapy.
Figure 3
Figure 3
Current major research topics and their countermeasures to overcome PRP’s shortcomings.
See this image and copyright information in PMC

References

    1. Kawase T. Platelet-rich plasma and its derivatives as promising bioactive materials for regenerative medicine: Basic principles and concepts underlying recent advances. Odontology. 2015;103:126–135. doi: 10.1007/s10266-015-0209-2. - DOI - PubMed
    1. Kawase T., Mubarak S., Mourão C.F. The Platelet Concentrates Therapy: From the Biased Past to the Anticipated Future. Bioengineering. 2020;7:82. doi: 10.3390/bioengineering7030082. - DOI - PMC - PubMed
    1. Aizawa H., Tsujino T., Watanabe T., Isobe K., Kitamura Y., Sato A., Yamaguchi S., Okudera H., Okuda K., Kawase T. Quantitative Near-Infrared Imaging of Platelets in Platelet-Rich Fibrin (PRF) Matrices: Comparative Analysis of Bio-PRF, Leukocyte-Rich PRF, Advanced-PRF and Concentrated Growth Factors. Int. J. Mol. Sci. 2020;21:4426. doi: 10.3390/ijms21124426. - DOI - PMC - PubMed
    1. Devereaux J., Dargahi N., Fraser S., Nurgali K., Kiatos D., Apostolopoulos V. Leucocyte-Rich Platelet-Rich Plasma Enhances Fibroblast and Extracellular Matrix Activity: Implications in Wound Healing. Int. J. Mol. Sci. 2020;21:6519. doi: 10.3390/ijms21186519. - DOI - PMC - PubMed
    1. Nakama G.Y., Gonzalez S., Matre P., Mu X., Whitney K.E., Utsunomiya H., Arner J.W., Philippon M.J., Ravuri S., Huard J. Effect of Oral Losartan on Orthobiologics: Implications for Platelet-Rich Plasma and Bone Marrow Concentrate—A Rabbit Study. Int. J. Mol. Sci. 2020;21:7374. doi: 10.3390/ijms21197374. - DOI - PMC - PubMed

Publication types

Substances